China’s health insurance market is at a pivotal stage of sustained scale expansion, profound structural transformation, and accelerating momentum shift. Its broad prospects and innovative vitality have attracted significant attention.
Scale and structural shifts are creating new opportunities
On market size, commercial health insurance premium income reached 997.3 billion yuan (approx. US$147.4bn) in 2025, just one step short of the 1-trillion-yuan threshold. Over the past decade, it has maintained robust growth, with a compound annual growth rate (CAGR) exceeding 20%, becoming an important pillar of the multi-tiered medical protection system.
On market structure, influenced by multiple factors, medical insurance is gradually overtaking critical illness insurance to become the dominant force in the health insurance market. In 2025, medical insurance premiums totalled approximately 455 billion yuan, accounting for 46% of the overall health insurance market and leading the industry with nearly 7% growth.
Characterised by lower price and higher leverage, medical insurance has become the market mainstay, driving the industry toward an ecosystem model of “insurance + health management + medical services.”
Three core drivers of long-term market prosperity
- Continued policy dividends are opening broad space for commercial insurance. As government-led DRG (Diagnosis Related Groups) and DIP (Diagnosis-Intervention Packet) reforms deepen, the boundaries of social insurance become clearer. This directly relieves pent-up demand for special-needs care, advanced therapies, and higher-quality healthcare experiences, creating a clear market position and development opportunity for commercial health insurance as an “effective complement.”
- Profound demographic changes are generating large and urgent protection needs. A quickly ageing population is driving massive demand for chronic disease management, disability risk mitigation, and long-term care services. This is pushing the evolution of health insurance products away from lump-sum critical-illness payouts toward comprehensive lifecycle solutions that include health management and care services.
- Dual forces of tech enablement and consumption upgrades are reshaping the industry ecosystem. Deep integration of AI and big data in China is being applied to precise risk pricing, intelligent underwriting and claims, and personalised health management, significantly improving operational efficiency and service experience. At the same time, public awareness of health and risk protection has risen in the post-pandemic era, and consumption upgrades have increased willingness to pay for higher-quality medical resources and forward-looking health protection. The interaction of these three drivers supports a move toward higher-quality, more sustainable development.
High-Potential Areas for Future Growth
These emerging sectors offer reinsurers precise entry points for deeper participation in China’s health insurance market:
- Rapid rise of mid-end medical insurance. Following “million-yuan” medical insurance and Huiminbao (a city-level, government-supported supplemental insurance program), mid-end medical insurance has become a “third growth curve” that meets upgraded consumer demand. Its core value lies in improving access to medical resources—covering inpatient and outpatient care in public hospital VIP and international departments, and in private hospitals—and extending to special, innovative drugs—precisely matching the urgent needs of upper-middle-income families for high-quality, efficient medical services. Reinsurers can support rapid expansion in mid-end medical insurance with extensive data, strong medical networks, and risk management expertise.
- Inclusion of people with pre-existing conditions and non-standard risk profiles. Breaking the traditional limitation of covering only “healthy lives,” this area aims to bring hundreds of millions of people with chronic conditions or pre-existing issues into coverage and is key to unlocking an incremental market. Product evolution is moving toward precise risk pricing and proactive health management, supported by big data and chronic-disease care. Development requires co-creation between insurers and reinsurers, with reinsurers providing more granular risk stratification and pricing support.
- Long-term care insurance as a vast blue ocean. This product directly addresses the social risk of “long life but disability,” and its demand closely matches China’s ageing reality. As national policy framework optimises, long-term care is expanding from pilot programs to diversified, market-oriented commercial products. In the future, it will deeply integrate with senior living communities, rehabilitation, and nursing-care industries, offering enormous market space. Operational models and experience from ageing markets in other countries may offer useful references for building robust commercial models in China.
Conclusion
Guy Carpenter believes that China’s health insurance market is entering a golden period of higher quality, better structure and broader coverage, driven by a large base and diverse growth drivers across multiple innovation tracks. For reinsurers, this is not only an opportunity for business growth but also a strategic window to combine their accumulated experience with local practice in China to jointly shape the industry’s future.